In Pennsylvania, researchers are using genomic profiling to help future treatment of pancreatic cancer, which is the third leading cause of cancer deaths in the United States and has a low survival rate of 8%. One study found a mutation in the anaplastic lymphoma kinase gene and used targeted therapy for the mutated gene. Another study used existing medicines to improve pancreatic cancer outcomes with similar genetic mutations. The key was using the targeted genetic therapy early on as they found patients who had advanced too far with pancreatic cancer did not benefit as much as patients who were in the earlier stages.
Latest article
UK utility extracting glucose from used TP
In the United Kingdom, water treatment company United Utilities is trialing a process at its Blackburn sewage works to extract glucose from used toilet...
Stella McCartney takes flight with plant-based feathers
In New York, sustainability-focused designer Stella McCartney used faux feathers made from plant-based materials in fashions exhibited at the recent Paris Fashion Week.
Produced...
Artificial Nature hits milestone scaling PLH
In Germany, Artificial Nature S.L. has scaled up production of its biobased and biodegradable copolyester PLH to 300 metric tons per year. The milestone...